Advanced Solid Tumors
813
189
235
323
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
106 trials with published results (13%)
Research Maturity
323 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.7%
103 terminated out of 813 trials
75.8%
-10.7% vs benchmark
0%
3 trials in Phase 3/4
33%
106 of 323 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 323 completed trials
Clinical Trials (813)
SKB565 for Injection in Advanced Solid Tumors
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
RVU120 Rollover Study
A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors